AbbVie, the global research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories has declared a quarterly cash dividend of $0.64 per share.
The company said that the cash dividend is payable May 15, 2017 to stockholders of record at the close of business on April 13, 2017.